Groundbreaking Global Survey Captures the Significant Patient Burden Experienced With Current Standard-Of-Care Bladder Cancer Treatments, Underscoring Urgency for Continued Innovation
May 15, 2026
May 15, 2026
RARITAN, New Jersey, May 15 (TNSrep) -- Johnson and Johnson Innovative Medicine issued the following news release:
* * *
Groundbreaking global survey captures the significant patient burden experienced with current standard-of-care bladder cancer treatments, underscoring urgency for continued innovation
- More than 90% of patients surveyed who underwent bladder removal or received BCG report negative impact on most aspects of their lives
- Amon . . .
* * *
Groundbreaking global survey captures the significant patient burden experienced with current standard-of-care bladder cancer treatments, underscoring urgency for continued innovation
- More than 90% of patients surveyed who underwent bladder removal or received BCG report negative impact on most aspects of their lives
- Amon . . .